Greg Lucier
Chairman and Chief Executive
biotechnology
Edico Genome
Japan
Biography
From May 2003 to February 2014, Mr. Lucier served as Chairman and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. Gregory T. Lucier has served as a member of the NuVasive Board of Directors since December 2013. During Mr. Lucier’s 11-year tenure at Life Technologies, he led the company from a small start-up known as Invitrogen in 2003, directed the acquisition and merger of Invitrogen with Applied Biosystems in 2008 into the renamed Life Technologies, and then transformed the organization by 2013 into a global, world-leading biotechnology firm with 50,000 products, 12,000 employees and nearly $4 billion in sales in more than 180 countries. Serving in his leadership role, Mr. Lucier was responsible for fostering a culture of excellence at Life Technologies and applied his more than 25 years of strategic management experience to help champion an era of personalized medicine. Mr. Lucier previously was a Corporate Officer of General Electric and served as an executive at GE Medical Systems. He received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School.
Research Interest
....
